Shoda T - Search Results

1

Design and synthesis of novel selective estrogen receptor degradation inducers based on the diphenylheptane skeleton.

Misawa T, Fujisato T, Kanda Y, Ohoka N, Shoda T, Yorioka M, Makishima M, Sekino Y, Naito M, Demizu Y, Kurihara M. Misawa T, et al. Among authors: shoda t. Medchemcomm. 2016 Dec 8;8(1):239-246. doi: 10.1039/c6md00553e. eCollection 2017 Jan 1. Medchemcomm. 2016. PMID: 30108709 Free PMC article.

2

Design and synthesis of estrogen receptor degradation inducer based on a protein knockdown strategy.

Demizu Y, Okuhira K, Motoi H, Ohno A, Shoda T, Fukuhara K, Okuda H, Naito M, Kurihara M. Demizu Y, et al. Among authors: shoda t. Bioorg Med Chem Lett. 2012 Feb 15;22(4):1793-6. doi: 10.1016/j.bmcl.2011.11.086. Epub 2011 Nov 28. Bioorg Med Chem Lett. 2012. PMID: 22277276

3

Design and synthesis of tamoxifen derivatives as a selective estrogen receptor down-regulator.

Shoda T, Okuhira K, Kato M, Demizu Y, Inoue H, Naito M, Kurihara M. Shoda T, et al. Bioorg Med Chem Lett. 2014 Jan 1;24(1):87-9. doi: 10.1016/j.bmcl.2013.11.078. Epub 2013 Dec 4. Bioorg Med Chem Lett. 2014. PMID: 24332630

4

Amphipathic short helix-stabilized peptides with cell-membrane penetrating ability.

Yamashita H, Demizu Y, Shoda T, Sato Y, Oba M, Tanaka M, Kurihara M. Yamashita H, et al. Among authors: shoda t. Bioorg Med Chem. 2014 Apr 15;22(8):2403-8. doi: 10.1016/j.bmc.2014.03.005. Epub 2014 Mar 13. Bioorg Med Chem. 2014. PMID: 24661993

5

Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation.

Hirata N, Yamada S, Shoda T, Kurihara M, Sekino Y, Kanda Y. Hirata N, et al. Among authors: shoda t. Nat Commun. 2014 Sep 25;5:4806. doi: 10.1038/ncomms5806. Nat Commun. 2014. PMID: 25254944 Free article.

6

Development of cell-penetrating R7 fragment-conjugated helical peptides as inhibitors of estrogen receptor-mediated transcription.

Nagakubo T, Demizu Y, Kanda Y, Misawa T, Shoda T, Okuhira K, Sekino Y, Naito M, Kurihara M. Nagakubo T, et al. Among authors: shoda t. Bioconjug Chem. 2014 Nov 19;25(11):1921-4. doi: 10.1021/bc500480e. Epub 2014 Nov 7. Bioconjug Chem. 2014. PMID: 25375254

7

Synthesis and evaluation of tamoxifen derivatives with a long alkyl side chain as selective estrogen receptor down-regulators.

Shoda T, Kato M, Harada R, Fujisato T, Okuhira K, Demizu Y, Inoue H, Naito M, Kurihara M. Shoda T, et al. Bioorg Med Chem. 2015 Jul 1;23(13):3091-6. doi: 10.1016/j.bmc.2015.05.002. Epub 2015 May 11. Bioorg Med Chem. 2015. PMID: 26003343

8

Synthesis and evaluation of raloxifene derivatives as a selective estrogen receptor down-regulator.

Shoda T, Kato M, Fujisato T, Misawa T, Demizu Y, Inoue H, Naito M, Kurihara M. Shoda T, et al. Bioorg Med Chem. 2016 Jul 1;24(13):2914-2919. doi: 10.1016/j.bmc.2016.04.068. Epub 2016 May 7. Bioorg Med Chem. 2016. PMID: 27185013

9

Tamoxifen and Fulvestrant Hybrids Showed Potency as Selective Estrogen Receptor Down-Regulators.

Shoda T, Kato M, Fujisato T, Demizu Y, Inoue H, Naito M, Kurihara M. Shoda T, et al. Med Chem. 2017;13(3):206-213. doi: 10.2174/1573406412666160805101408. Med Chem. 2017. PMID: 27494098

10

Development of BCR-ABL degradation inducers via the conjugation of an imatinib derivative and a cIAP1 ligand.

Demizu Y, Shibata N, Hattori T, Ohoka N, Motoi H, Misawa T, Shoda T, Naito M, Kurihara M. Demizu Y, et al. Among authors: shoda t. Bioorg Med Chem Lett. 2016 Oct 15;26(20):4865-4869. doi: 10.1016/j.bmcl.2016.09.041. Epub 2016 Sep 15. Bioorg Med Chem Lett. 2016. PMID: 27666635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

256 results

Search Page

Filters